Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients Treated With Epidermal Growth Factor Receptor Inhibitors and Capecitabine.
Where this comes from
- Record sourced from PubMed, PMID 29117285.
- Also identified by DOI 10.1001/jamadermatol.2017.4120 and PMC identifier 5833586.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study evaluated the efficacy and tolerability of topical timolol, 0.5%, gel as a treatment of paronychia and pseudopyogenic granuloma induced by antineoplastic agents.
Medical subject headings
- Angiolymphoid Hyperplasia with Eosinophilia
- Antimetabolites, Antineoplastic
- Capecitabine
- Paronychia
- Timolol